Ilya Pharma
Phase 2Developing the next-generation biological drugs for treating wounds in skin and mucosa
Founded
2016
Focus
Microbiome
About
Developing the next-generation biological drugs for treating wounds in skin and mucosa
Funding History
2Total raised: $27.2M
Series A$24MFlerie InvestMar 15, 2022
Seed$3.2MUppsala University HoldingMay 15, 2019
Company Info
TypePrivate
Founded2016
LocationUppsala, Sweden
StagePhase 2
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile